Assessment of osteosarcoma response to neoadjuvant chemotherapy: Comparative usefulness of dynamic gadolinium-enhanced spin-echo magnetic resonance imaging and technetium-99m skeletal angioscintigraphy

European Radiology

Volumn 9, Issue 5, 1999, Pages 907-914

  Ongolo Zogo, P ^a   Thiesse, P ^a   Sau, J ^b   Desuzinges, C ^a   Blay, J Y ^a   Bonmartin, A ^b   Bochu, M ^a   Philip, T ^b  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITÉ LYON 1   (France)

Author keywords

Chemotherapy; Comparative studies; Contrast enhancement; Gadolinium; MR imaging; Osteosarcoma; Radionuclide imaging; Technetium 99m

Indexed keywords

CONTRAST MEDIUM; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GADOLINIUM 1,4,7,10-TETRAAZACYCLODODECANE-N,N',N'',N'''-TETRAACETATE; GADOLINIUM PENTETATE; GADOTERIC ACID; HETEROCYCLIC COMPOUND; MEDRONATE TECHNETIUM TC 99M; ORGANOMETALLIC COMPOUND; RADIOPHARMACEUTICAL AGENT; TECHNETIUM TC 99M HYDROXYMETHYLENE DIPHOSPHONATE;

ADJUVANT CHEMOTHERAPY; ADOLESCENT; ADULT; ARTICLE; BONE; BONE TUMOR; CHILD; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOSARCOMA; PATHOLOGY; PROSPECTIVE STUDY; SCINTISCANNING;

ADOLESCENT; ADULT; BONE AND BONES; BONE NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CHILD; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HETEROCYCLIC COMPOUNDS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; ORGANOMETALLIC COMPOUNDS; OSTEOSARCOMA; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M MEDRONATE;

EID: 0032610141     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003300050765     Document Type: Article

References (35)

1. Rosen G, Caparros B, Huvos AG et al. (1982) Preoperative chemotherapy for osteogenic sarcoma: selection of post-operative adjuvant chemotherapy based on the response of the primary neoplasm to preoperative chemotherapy. Cancer 49: 1221-1230
2. FNCLCC (1995) Standards, options et recommendations: Sarcomes des tissus mous et ostéosarcomes. Arnette Blackwell, Paris
3. Bentzen SM, Poulsen HS, Kaae S et al. (1988) Prognostic factors in osteosarcomas: a regression analysis. Cancer 62: 194-202
4. Glasser DB, Lane JM, Huvos AG, Marcove RC, Rosen G (1992) Survival, prognosis, and therapeutic response in osteogenic sarcoma. Cancer 69: 698-708
5. Meyers PA, Healey J, Huvos A et al. (1992) Chemotherapy for non-metastatic osteogenic sarcoma. The Memorial Sloan-Kettering experience. J Clin Oncol 10: 5-15
6. Bacci G, Picci P, Ferrari S et al. (1993) Primary chemotherapy and delayed surgery for non-metastatic osteosarcoma of the extremities. Cancer 72: 3227-3238
7. Davis AM, Bell RS, Goodwin PJ (1994) Prognostic factors in osteosarcoma: a critical review. J Clin Oncol 12: 423-431
8. Smith J, Heelan RT, Huvos AG et al. (1982) Radiographic changes in primary osteogenic sarcoma following intensive chemotherapy: radiological pathological correlation in 63 patients. Radiology 143: 355-360
9. Holscher HC, Hermans J, Nooy MA, Taminiau AHM, Hogendoorn PCW, Bloem JL (1996) Can conventional radiographs be used to monitor the effect of neoadjuvant chemotherapy in patients with osteogenic sarcoma? Skeletal Radiol 25: 19-24
10. Mail JT, Cohen MD, Mirkin LD, Provisor AJ (1985) Response of osteosarcoma to preoperative intravenous high dose methotrexate chemotherapy: CT evaluation. AJR 144: 89-93
11. Kumpan W, Lechner G, Wittich GR et al. (1986) The angiographic response of osteosarcoma following preoperative chemotherapy. Skeletal Radiol 15: 96-102
12. Carrasco CH, Charnsangavej C, Raymond AK et al. (1989) Osteosarcoma: angiographic assessment of response to preoperative chemotherapy. Radiology 170: 839-842
13. Fletcher BD (1991) Response of osteosarcoma and Ewing sarcoma to chemotherapy: imaging evaluation. AJR 157: 825-833
14. Erlemann R, Sciuk J, Bosse A et al. (1990) Response of osteosarcoma and Ewing sarcoma to preoperative chemotherapy: assessment with dynamic and static MR imaging and skeletal scintigraphy. Radiology 175: 791-796
15. Van Der Woude HJ, Bloem JL, Schipper J et al. (1994) Changes in neoplasm perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy. Radiology 191: 421-431
16. Erlemann R, Reiser MF, Peters PE et al. (1989) Musculoskeletal neoplasms: static and dynamic Gd-DTPA-enhanced MR imaging. Radiology 171: 767-773
17. Bonnerot V, Charpentier A, Frouin F, Kalifa C, Vanel D, Paola R di (1992) Factor analysis of dynamic magnetic resonance imaging in predicting the response of osteosarcoma to chemotherapy. Invest Radiol 27: 847-855
18. Fletcher BD, Hanna SL, Fairclough DL, Gronemeyer SA (1992) Pediatric musculoskeletal neoplasms: use of dynamic, contrast enhanced MR imaging to monitor response to chemotherapy. Radiology 184: 243-248
19. Hanna SL, Parham DM, Fairclough DL, Meyer WH, Le AH, Fletcher BD (1992) Assessment of osteosarcoma response to preoperative chemotherapy using dynamic FLASH gadolinium-DTPA-enhanced magnetic resonance mapping. Invest Radiol 27: 367-373
20. Hanna SL, Reddick WE, Parham DM, Gronemeyer SA, Taylor JS, Fletcher BD (1993) Automated pixel-by-pixel mapping of dynamic contrast-enhanced MR images for evaluation of osteosarcoma response to chemotherapy: preliminary results. J Magn Reson Imaging 3: 849-853
21. Van Der Woude HJ, Bloem JL, Verstraete KL, Taminiau AHM, Nooy MA, Hogendoorn PCW (1995) Osteosarcoma and Ewing sarcoma after neoadjuvant chemotherapy: value of dynamic MR imaging in detecting viable neoplasm before surgery. AJR 165: 593-598
22. Weinmann HJ, Brasch RC, Press WR, Wesbey GE (1984) Characteristics of gadolinium-DTPA complex: a potential NMR contrast agent. AJR 142: 619-624
23. Lang P, Honda G, Roberts T et al. (1995) Musculoskeletal neoplasm: perineoplastic edema versus neoplasm on dynamic post-contrast MR images with spatial mapping of instantaneous enhancement rates. Radiology 197: 831-839
24. Huvos AG, Rosen G, Marcove RC (1977) Primary osteogenic sarcoma. Pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement. Arch Pathol Lab Med 101: 14-18
25. Holscher HC, Bloem JL, Vanel D et al. (1992) Osteosarcoma: chemotherapy-induced changes at MR imaging. Radiology 182: 839-844
26. Holscher HC, Bloem JL, Van der Woude HJ et al. (1995) Can MRI predict the histopathological response in patients with osteosarcoma after the first cycle of chemotherapy? Clin Radiol 50: 384-390
27. Fletcher BD, Reddick WE, Taylor JS, Lang P (1996) Dynamic MR imaging of musculoskeletal neoplasms (letters). Radiology 200: 869-872
28. Knop J, Delling G, Heise U, Winkler K (1990) Scintigraphic evaluation of neoplasm regression during preoperative chemotherapy of osteosarcoma. Skeletal Radiol 19: 165-172
29. Edeline V, Frouin F, Bazin JP et al. (1993) Factor analysis as a means of determining response to chemotherapy in patients with osteogenic sarcoma. Eur J Nucl Med 20: 1175-1185
30. Erlemann R, Fletcher BD (1993) Dynamic, gadolinium-enhanced MR imaging to monitor neoplasm response to chemotherapy (letters). Radiology 186: 904-905
31. Lagergren C, Lindbom A, Soderberg G (1961) The blood vessels of osteogenic sarcomas. Acta Radiol 55: 161-176
32. Vaupel P, Kallinowski F, Okunieff P (1989) Blood flow oxygen and nutriment supply, and metabolic microenvironnement of human neoplasms. Cancer Res 49: 6449-6465
33. Holder LE (1990) Clinical radionuclide bone imaging. Radiology 176: 607-614
34. Siegel BA, Donovan RL, Alderson PO, Marek GR (1976) Skeletal uptake of 99mTc-diphosphonate in relation to local bone blood flow. Radiology 120: 121-123
35. Nutton RW, Fitzgerald R, Kelly PJ (1985) Early dynamic bone-imaging as an indicator of osseous blood flow and factors affecting the uptake of Tc99 m hydroxymethylene diphosphonate in healing bone. J Bone Joint Surg 67A:763-770